Pharmaceutics (Sep 2021)

Endothelial-Derived Extracellular Vesicles Induce Cerebrovascular Dysfunction in Inflammation

  • David Roig-Carles,
  • Eduard Willms,
  • Ruud D. Fontijn,
  • Sarai Martinez-Pacheco,
  • Imre Mäger,
  • Helga E. de Vries,
  • Mark Hirst,
  • Basil Sharrack,
  • David K. Male,
  • Cheryl A. Hawkes,
  • Ignacio A. Romero

DOI
https://doi.org/10.3390/pharmaceutics13091525
Journal volume & issue
Vol. 13, no. 9
p. 1525

Abstract

Read online

Blood–brain barrier (BBB) dysfunction is a key hallmark in the pathology of many neuroinflammatory disorders. Extracellular vesicles (EVs) are lipid membrane-enclosed carriers of molecular cargo that are involved in cell-to-cell communication. Circulating endothelial EVs are increased in the plasma of patients with neurological disorders, and immune cell-derived EVs are known to modulate cerebrovascular functions. However, little is known about whether brain endothelial cell (BEC)-derived EVs themselves contribute to BBB dysfunction. Human cerebral microvascular cells (hCMEC/D3) were treated with TNFα and IFNy, and the EVs were isolated and characterised. The effect of EVs on BBB transendothelial resistance (TEER) and leukocyte adhesion in hCMEC/D3 cells was measured by electric substrate cell-substrate impedance sensing and the flow-based T-cell adhesion assay. EV-induced molecular changes in recipient hCMEC/D3 cells were analysed by RT-qPCR and Western blotting. A stimulation of naïve hCMEC/D3 cells with small EVs (sEVs) reduced the TEER and increased the shear-resistant T-cell adhesion. The levels of microRNA-155, VCAM1 and ICAM1 were increased in sEV-treated hCMEC/D3 cells. Blocking the expression of VCAM1, but not of ICAM1, prevented sEV-mediated T-cell adhesion to brain endothelia. These results suggest that sEVs derived from inflamed BECs promote cerebrovascular dysfunction. These findings may provide new insights into the mechanisms involving neuroinflammatory disorders.

Keywords